By your side for a healthier world™

Items in my cart

Loading your cart..
  1. Home

    2. Blog

The West Blog

Subscribe to receive the latest blog post
Latest Post

December 28, 2020

Particles in Injectable Drugs

A parenteral drug product contaminated by particles is a potential health threat. In the bloodstream, particles can cause serious issues, such as capillary occlusion and immunogenic responses. In most cases, the observation of particles in a drug product leads to a recall.
View Post
Lynn Yao

Lynn Yao

Manager, Scientific Affairs, CN

Categories

Search the Blog

Archive

{1}

{2}
{3}

{4}

    • Previous Posts
    Ready Pack System

    December 04, 2020

    How to get your biologic approved quickly when you don’t have the resources of big pharma

    Abigail Hisler

    Abbey Hisler

    Director, Segment Marketing, Biologics

    Integrated Solutions Program Graph

    September 11, 2020

    Introducing West’s New Interactive Integrated Solutions Webpage

    Shari Krusniak

    Shari Krusniak

    Director, Marketing, Contract Manufacturing & Integrated Solutions

    SmartDose in use.

    August 14, 2020

    How the FDA PFDD initiative is bringing the patients voice earlier into drug development

    Victoria Morgan

    Victoria Morgan

    Global Director, Segment Marketing

    May 08, 2020

    Daikyo Crystal Zenith® Cyclic Olefin Polymer – the Right Polymer for Drug Product Packaging

    Page McAndrew

    Page McAndrew, PhD.

    Director, Scientific Communications

    Compounding Pharmacy drug products

    May 01, 2020

    Injectable Combination Product Development: Facilitating Risk-Based Assessments for Efficiency and Patient Centric Outcomes

    Fran DeGrazio

    Fran DeGrazio

    Chief Scientific Officer, Strategy & Science Integration

    Revision

    April 13, 2020

    Revised Drug Administration Law of the People’s Republic of China

    Lynn Yao

    Lynn Yao

    Manager, Scientific Affairs, China

    Load more